Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 1, 2016, Pages 13-22.e1

  Lucendo, Alfredo J ^a   Arias, Ángel ^b   Molina Infante, Javier ^c  

^a Hospital General de Tomelloso   (Spain)

^b HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^c HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

Eosinophilic esophagitis; Esomeprazole; Lansoprazole; Meta analysis; Omeprazole; Proton pump inhibitors; Rabeprazole; Systematic review

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; CHILD; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; EOSINOPHILIC ESOPHAGITIS; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PH; PUBLISHING; REMISSION; REVIEW; ESOPHAGUS; PATHOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; HUMANS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 84957309475     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.07.041     Document Type: Review

References (53)

1. Liacouras C.A., Furuta G.T., Hirano I., et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011, 128:3-20.
2. Attwood S.E., Smyrk T.C., Demeester T.R., et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993, 38:109-116.
3. Straumann A., Spichtin H.P., Bernoulli R., et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr 1994, 124:1419-1429.
4. Hruzp P., Straumann A., Bussmann C., et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 2011, 128:1349-1350.
5. Arias A., Lucendo A.J. Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol 2013, 25:208-212.
6. Dellon E.S., Jensen E.T., Martin C.F., et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol 2014, 12:589-596.
7. Furuta G.T., Liacouras C.A., Collins M.H., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133:1342-1363.
8. Dellon E.S., Gonsalves N., Hirano I., et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013, 108:679-692.
9. Papadopoulou A., Koletzko S., Heuschkel R., et al. Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr 2014, 58:107-118.
10. Spechler S.J., Genta R.M., Souza R.F. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007, 102:1301-1306.
11. Ngo P., Furuta G.T., Antonioli D.A., et al. Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006, 101:1666-1670.
12. Sayej W.N., Patel R., Baker R.D., et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009, 49:393-399.
13. Dranove J.E., Horn D.S., Davis M.A., et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr 2009, 154:96-100.
14. Molina-Infante J., Ferrando-Lamana L., Ripoll C., et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011, 9:110-117.
15. Molina-Infante J., Katzka D.A., Dellon E.S. Proton pump inhibitor-responsive esophageal eosinophilia: a historical perspective on a novel and evolving entity. Rev Esp Enferm Dig 2015, 107:29-36.
16. Molina-Infante J., Katzka D.A., Gisbert J.P. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis. Aliment Pharmacol Ther 2013, 37:1157-1164.
17. Urrútia G., Bonfill X. PRISMA declaration: a proposal to improve the publication of systematic reviews and meta-analyses. Med Clin (Barc) 2010, 135:507-511.
18. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions (version 5.1.0). The Cochrane Collaboration 2011. Available from: Accessed: June 23, 2015. http://www.handbook.cochrane.org.
19. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
20. von Elm E., Altman D.G., Egger M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007, 18:800-804.
21. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
22. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
23. Harbord R.M., Egger M., Sterne J.A. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006, 25:3443-3457.
24. Nurko S., Teitelbaum J., Husain K., et al. Association of Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr 2004, 38:431-441.
25. Cury E.K., Schraibman V., Faintuch S. Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children-discussion on daily practice. J Pediatr Surg 2004, 39:e4-e7.
26. Potter J.W., Saeian K., Staff D., et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc 2004, 59:355-361.
27. Nantes C.O., Zozaya J.M., Jimenez-Perez F.J., et al. Incidence and characteristics of eosinophilic esophagitis in adults. An Sist Sanit Navar 2009, 32:227-234.
28. Peterson K.A., Thomas K.L., Hilden K., et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2010, 55:1313-1319.
29. Jung Y.M., Lee H.S., Lee D.H., et al. Clinical significance of incidentally detected eosinophilic esophagitis with pathologic review. Korean J Gastroenterol 2010, 55:162-168.
30. Abe Y., Iijima K., Ohara S., et al. A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol 2011, 46:25-30.
31. Fujiwara Y., Sugawa T., Tanaka F., et al. A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration. Intern Med 2012, 51:3235-3239.
32. Dohil R., Newbury R.O., Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci 2012, 57:1413-1419.
33. Levy A.N., Rahaman S.M., Bonis P.A., et al. Hiccups as a presenting symptom of eosinophilic esophagitis. Case Rep Gastroenterol 2012, 6:340-343.
34. Francis D.L., Foxx-Orenstein A., Arora A.S., et al. Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis. Aliment Pharmacol Ther 2012, 35:300-307.
35. Vazquez-Elizondo G., Ngamruengphong S., Khrisna M., et al. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther 2013, 38:1312-1319.
36. Tomomatsu Y., Yoshino J., Inui K., et al. Clinical features of eosinophilic esophagitis: ten Japanese cases. Dig Endosc 2013, 25:117-124.
37. Schroeder S., Capocelli K.E., Masterson J.C., et al. Effect of proton pump inhibitor on esophageal eosinophilia. J Pediatr Gastroenterol Nutr 2013, 56:166-172.
38. Rea F., Caldaro T., Tambucci R., et al. Eosinophilic esophagitis: is it also a surgical disease?. J Pediatr Surg 2013, 48:304-308.
39. Moawad F.J., Veerappan G.R., Dias J.A., et al. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol 2013, 108:366-372.
40. Lee J.H., Kim M.J., Kim J.H., et al. Clinical analysis of primary eosinophilic esophagitis. J Neurogastroenterol Motil 2013, 19:204-209.
41. Dellon E.S., Speck O., Woodward K., et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013, 108:1854-1860.
42. Yilmaz O., Karagol H.I., Topal E., et al. Two cases of esophageal eosinophilia: eosinophilic esophagitis or gastro-esophageal reflux disease?. Pediatr Rep 2014, 6:5160.
43. Lipka S., Muhammad A., Champeaux A., et al. Case report of proton pump inhibitor responsive esophageal eosinophilia: why 2 months of proton pump inhibitors is required. Dis Esophagus 2014, Epub ahead of print.
44. Molina-Infante J., Dueñas-Sadornil C., Rivas M.D., et al. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther 2014, 40:955-965.
45. Dhaliwal J., Tobias V., Sugo E., et al. Eosinophilic esophagitis in children with esophageal atresia. Dis Esophagus 2015, 27:340-347.
46. van Rhijn B.D., Weijenborg P.W., Verheij J., et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014, 12:1815-1823.
47. Garrean C.P., Patil D., Gonsalves N., et al. Comparison of endoscopic and histologic response in patients with eosinophilic esophagitis treated with proton pump inhibition, topical fluticasone, and dietary elimination. Gastroenterology 2009, 136(Suppl 1):A-279.
48. Gortani G., Pastore S., Rubert L., et al. Peptic of allergic eosinophilic esophagitis?. Dig Liver Dis 2009, 41(Suppl 3):S-215.
49. Cohen-Sabban J., Donato G., Christiansen S., et al. Coexistence of eosinophilic esophagitis with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2012, 51(Suppl 2):E18.
50. Martinek J., Strosova A., Stefanova M., et al. Treatment with proton pump inhibitors is effective in a majority of adults patients with eosinophilic esophagitis. Gastroenterology 2015, 144(Suppl 1):S-493.
51. Mangla S., Singal G., Hornick J.L., et al. Clinical predictors of response to proton pump inhibitors in patients with esophageal eosinophilia. Gastroenterology 2014, 146(Suppl 1):S-496.
52. Yamada Y., Nishi A., Watanabe S., et al. Esophageal eosinophilia associated with congenital esophageal atresia/stenosis and its responsiveness to proton pump inhibitor. J Allergy Clin Immunol 2015, 135:AB45.
53. Dellon E.S., Aderoju A., Woosley J.T., et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007, 102:2300-2313.